ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026
Real-World Effectiveness and Safety of Imeglimin in Type 2 Diabetes: Prospective Multi-Center Study in Bangladesh.
Shahjada Selim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.